Facebook
Twitter
Telegram
Report an ErrorPoseida Therapeutics Cash Flow 2011-2024 | PSTX
Annual Cash Flow Poseida Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-92.2 M | -26.8 M | -103 M | -113 M | -64.5 M | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
5.61 M | 5.17 M | 4.55 M | 2.59 M | 1.19 M | - | - | - | - | - | - | - | - |
Accounts Payables |
3.27 M | 2.23 M | 8.96 M | 763 K | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
9.01 M | 9.09 M | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Poseida Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-15.1 M | - | - | - | -38 M | - | -29.2 M | -91.1 M | -51.3 M | - | -111 M | -70.1 M | -39.1 M | - | -83 M | -53.7 M | -22.9 M | - | -64.4 M | -64.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
1.38 M | - | 1.4 M | 1.4 M | 1.32 M | - | 1.4 M | 1.3 M | 1.21 M | - | 1.2 M | 1.1 M | 1.07 M | - | 700 K | 500 K | 416 K | - | 807 K | 460 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.7 M | 3.27 M | 2.54 M | 2.1 M | 3.2 M | 2.23 M | 3.43 M | 3.66 M | 3.59 M | 8.96 M | 3.64 M | 4.51 M | 2.49 M | 763 K | 763 K | 763 K | 763 K | 4.93 M | 4.93 M | 4.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
12 M | 9.01 M | 8.67 M | 11.9 M | 8.44 M | 9.09 M | 38.5 M | 232 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency